MOUNTAIN LAKE ACQUISITION CO (MLACR) Fundamental Analysis & Valuation

NASDAQ:MLACR

Current stock price

0.255 USD
-0.01 (-3.77%)
Last:

This MLACR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MLACR Profitability Analysis

1.1 Basic Checks

  • MLACR had positive earnings in the past year.
  • In the past year MLACR has reported a negative cash flow from operations.
  • Of the past 5 years MLACR 4 years were profitable.
  • In the past 5 years MLACR always reported negative operating cash flow.
MLACR Yearly Net Income VS EBIT VS OCF VS FCFMLACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 3.42%
ROE 3.45%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MLACR Yearly ROA, ROE, ROICMLACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MLACR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLACR Yearly Profit, Operating, Gross MarginsMLACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. MLACR Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for MLACR remains at a similar level compared to 1 year ago.
  • MLACR has more shares outstanding than it did 5 years ago.
  • There is no outstanding debt for MLACR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MLACR Yearly Shares OutstandingMLACR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2024 2025 10M 20M 30M
MLACR Yearly Total Debt VS Total AssetsMLACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 3.80 indicates that MLACR is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for MLACR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.8
ROIC/WACCN/A
WACCN/A
MLACR Yearly LT Debt VS Equity VS FCFMLACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.93 indicates that MLACR should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.93 indicates that MLACR should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.93
Quick Ratio 1.93
MLACR Yearly Current Assets VS Current LiabilitesMLACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2024 2025 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MLACR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 440.00% over the past year.
  • The earnings per share for MLACR have been decreasing by -12.01% on average. This is quite bad
EPS 1Y (TTM)440%
EPS 3Y-12.01%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

2

4. MLACR Valuation Analysis

4.1 Price/Earnings Ratio

  • MLACR is valuated cheaply with a Price/Earnings ratio of 0.94.
  • MLACR is valuated cheaply when we compare the Price/Earnings ratio to 27.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.94
Fwd PE N/A
MLACR Price Earnings VS Forward Price EarningsMLACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLACR Per share dataMLACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MLACR Dividend Analysis

5.1 Amount

  • No dividends for MLACR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MLACR Fundamentals: All Metrics, Ratios and Statistics

MOUNTAIN LAKE ACQUISITION CO

NASDAQ:MLACR (4/17/2026, 8:00:00 PM)

0.255

-0.01 (-3.77%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-20
Earnings (Next)05-11
Inst Owners99.95%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.90M
Revenue(TTM)N/A
Net Income(TTM)8.28M
AnalystsN/A
Price TargetN/A
Short Float %0.04%
Short Ratio0.52
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.94
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.03
P/tB 0.03
EV/EBITDA N/A
EPS(TTM)0.27
EY105.88%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS7.77
TBVpS7.77
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.86925 (2593.82%)
Profitability
Industry RankSector Rank
ROA 3.42%
ROE 3.45%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.93
Quick Ratio 1.93
Altman-Z 3.8
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)440%
EPS 3Y-12.01%
EPS 5YN/A
EPS Q2Q%0%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2500%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-481.25%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-481.25%
OCF growth 3YN/A
OCF growth 5YN/A

MOUNTAIN LAKE ACQUISITION CO / MLACR Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MOUNTAIN LAKE ACQUISITION CO (MLACR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to MLACR.


What is the valuation status of MOUNTAIN LAKE ACQUISITION CO (MLACR) stock?

ChartMill assigns a valuation rating of 2 / 10 to MOUNTAIN LAKE ACQUISITION CO (MLACR). This can be considered as Overvalued.


How profitable is MOUNTAIN LAKE ACQUISITION CO (MLACR) stock?

MOUNTAIN LAKE ACQUISITION CO (MLACR) has a profitability rating of 1 / 10.


What are the PE and PB ratios of MOUNTAIN LAKE ACQUISITION CO (MLACR) stock?

The Price/Earnings (PE) ratio for MOUNTAIN LAKE ACQUISITION CO (MLACR) is 0.94 and the Price/Book (PB) ratio is 0.03.